BH3 mimetic-elicited Ca2+ signals in pancreatic acinar cells are dependent on Bax and can be reduced by Ca2+-like peptides by Ferdek, Pawel E. et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/97737/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Ferdek, Pawel, Jakubowska, Monika, Polina, Nicolaou, Gerasimenko, Julia, Gerasimenko, Oleg and
Petersen, Ole 2017. BH3 mimetic-elicited Ca2+ signals in pancreatic acinar cells are dependent on
Bax and can be reduced by Ca2+-like peptides. Cell Death and Disease 8 , e2640.
10.1038/cddis.2017.41 file 
Publishers page: http://dx.doi.org/10.1038/cddis.2017.41 <http://dx.doi.org/10.1038/cddis.2017.41>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
OPEN
BH3 mimetic-elicited Ca2+ signals in pancreatic acinar
cells are dependent on Bax and can be reduced by
Ca2+-like peptides
Pawel E Ferdek*,1, Monika A Jakubowska1, Polina Nicolaou1,3, Julia V Gerasimenko1, Oleg V Gerasimenko1 and Ole H Petersen1,2
BH3 mimetics are small-molecule inhibitors of B-cell lymphoma-2 (Bcl-2) and Bcl-xL, which disrupt the heterodimerisation of anti-
and pro-apoptotic Bcl-2 family members sensitising cells to apoptotic death. These compounds have been developed as anti-
cancer agents to counteract increased levels of Bcl-2 proteins often present in cancer cells. Application of a chemotherapeutic
drug supported with a BH3 mimetic has the potential to overcome drug resistance in cancers overexpressing anti-apoptotic
Bcl-2 proteins and thus increase the success rate of the treatment. We have previously shown that the BH3 mimetics, BH3I-2′ and
HA14-1, induce Ca2+ release from intracellular stores followed by a sustained elevation of the cytosolic Ca2+ concentration. Here we
demonstrate that loss of Bax, but not Bcl-2 or Bak, inhibits this sustained Ca2+ elevation. What is more, in the absence of Bax,
thapsigargin-elicited responses were decreased; and in two-photon-permeabilised bax−/− cells, Ca2+ loss from the ER was
reduced compared to WT cells. The Ca2+-like peptides, CALP-1 and CALP-3, which activate EF hand motifs of
Ca2+-binding proteins, significantly reduced excessive Ca2+ signals and necrosis caused by two BH3 mimetics: BH3I-2′ and
gossypol. In the presence of CALP-1, cell death was shifted from necrotic towards apoptotic, whereas CALP-3 increased the
proportion of live cells. Importantly, neither of the CALPs markedly affected physiological Ca2+ signals elicited by ACh, or
cholecystokinin. In conclusion, the reduction in passive ER Ca2+ leak in bax−/− cells as well as the fact that BH3 mimetics trigger
substantial Ca2+ signals by liberating Bax, indicate that Bax may regulate Ca2+ leak channels in the ER. This study also
demonstrates proof-of-principle that pre-activation of EF hand Ca2+-binding sites by CALPs can be used to ameliorate excessive
Ca2+ signals caused by BH3 mimetics and shift necrotic death towards apoptosis.
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Disrupted regulation of apoptosis is the hallmark of carcino-
genesis allowing accumulation of further genetic mutations
and acquisition of metastatic properties.1 Cancer cells often
express increased levels of anti-apoptotic Bcl-2 (B-cell
lymphoma-2) proteins, which provides additional protection
against cell death signals2,3 correlating with chemotherapy
resistance and poor prognosis for patients.4
As anti-cancer therapies often target the mitochondrial
apoptotic pathway regulated by the Bcl-2 family, overexpres-
sion of anti-apoptotic proteins in cancer presents one of the
leading challenges to overcome for effective treatment.5
Mechanism of apoptosis induction in cancer is predominantly
altered upstream of Bax and Bak.6 Therefore pharmacological
suppression of anti-apoptotic Bcl-2 members leading to
activation of Bax and Bak should, in principle, be capable of
recovering the programmed cell death.7,8
BH3 mimetics are small-molecule synthetic inhibitors of
Bcl-2 and Bcl-xL, specifically developed as anti-cancer
agents.7 Theymimic activated BH3-only proteins by disrupting
the heterodimerisation of anti- and pro-apoptotic Bcl-2 family
members, and thus sensitising cells to apoptosis. HA14-1 was
the first BH3mimetic obtained bymolecular modelling that had
the ability to displace Bax from Bcl-2, followed by the induction
of cell death.7 Later, a family of seven members of BH3
mimetics, called BH3 inhibitors (BH3Is), was developed and
shown to displace Bak peptide from Bcl-xL, trigger apoptosis,
cytochrome c release and caspase activation.9 A natural BH3
mimetic gossypol, isolated from the cotton plant (Gossypium),
is also capable of inhibiting Bcl-2, Bcl-xL and Mcl-1.10,11
Simultaneous application of a chemotherapeutic agent and
a BH3 mimetic can potentially overcome drug resistance in
cancers overexpressing anti-apoptotic Bcl-2 proteins and thus
increase the treatment success rate. BH3I-2′ and HA14-1
were shown to sensitise leukaemic cells in vitro to TRAIL-
induced apoptosis.12Gossypol (AT-101) was found to increase
radiation efficacy in head and neck cancer cell lines in vitro;13
and recently underwent phase II clinical trials in combination
with docetaxel14 and with androgen deprivation therapy.15
A particularly interesting approach is to develop chemically
tailored BH3 mimetics that interact specifically with the anti-
apoptotic proteins overexpressed in a target cancer type.8
As exciting as the prospect of Bcl-2 inhibition might seem,
accumulating evidence shows that BH3 mimetics often affect
intracellular Ca2+ homoeostasis. Previously we have reported
that HA14-1 and BH3I-2′ deplete the ER Ca2+ store causing a
sustained elevated cytosolic Ca2+ concentration in pancreatic
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acinar cells (PACs).16 Others have demonstrated that HA14-1
causes Ca2+ deregulation in platelets, HeLa and HEK-293T
cells.17 This immediately triggers questions about safe and
specific use of BH3 mimetics, especially given the crucial role
of Ca2+ in the regulation of a wide variety of intracellular
process including muscle contraction,18 enzyme secretion,19
fertilisation,20,21 cell proliferation22 and death.23 This is
particularly important in the pancreas, as physiological Ca2+
oscillations control enzyme secretion in PACs, whereas
abnormal Ca2+ signals are the hallmark of the initial stages
of a severe necrotising disease of the pancreas – acute
pancreatitis.24–26 This study aims to assess the effects of BH3
mimetics on Ca2+ handling in relation to activation of pro-
apoptotic Bax in PACs. Also, we draw conclusions about the
involvement of Bax in intracellular Ca2+ signalling and propose
means to reduce the excessive Ca2+ signals enabling
modulation of the cell death mechanisms.
Results
Ca2+ responses to BH3 mimetics in pancreatic acinar
cells are dependent on Bax. BH3I-2′ and HA14-1 were
shown to induce a slow Ca2+ release from the intracellular
stores.16 Pharmacological inhibition of inositol 1,4,5-tripho-
sphate receptors (IP3Rs) and ryanodine receptors (RyRs) led
to a decreased Ca2+ release from the ER of permeabilised
PACs but did not completely block it. This indicates that IP3Rs
and RyRs were not the primary source of BH3 mimetic-
elicited Ca2+ release but merely amplified it.16 Here PACs,
isolated from wild-type (WT) mice as well as animals with a
loss-of-function mutation in one of the following genes: bcl-2,
bak or bax were treated with 5 μM BH3I-2′ (Figure 1a) or
30 μM HA14-1 (Figure 1b) in the absence of extracellular
Ca2+. In WT, bcl-2−/− and bak−/− cells, these BH3 mimetics
caused sustained elevations of the cytosolic Ca2+ concentra-
tion ([Ca2+]i), whereas in bax
−/− cells the Ca2+ signal
generation was largely abolished (Figures 1a and b).
Quantitative comparison of the responses to BH3I-2′
(Figure 1c) and HA14-1 (Figure 1d) confirmed that loss of
Bax, but not Bcl-2 or Bak, dramatically inhibited the BH3
mimetic-induced elevation of the [Ca2+]i (Po0.001). The
responses to BH3I-2′ or HA14-1 in bax−/− cells, if present at
all, were mainly short-lasting Ca2+ transients, whereas
sustained elevation was mostly inhibited (Figures 1e and f).
Further, measurements of Ca2+ release from the ER in two-
photon-permeabilised PACs revealed that BH3I-2′ not only
appears to release less Ca2+ from the ER of bax−/− compared
to WT cells (Po0.01; Figures 2a and b) but also that the
apparent rate of release was slower than in WT cells.
Consequently, τ1/2 for bax
−/− (226.5± 25.9 s) cells was higher
than for WT cells (145.1±19.3 s; Po0.05; Figure 2c), which
translates into longer time needed for the fluorescence of the
Ca2+ indicator to decrease by half the difference between
baseline and final values. Images of a PAC doublet before
and after laser permeabilisation are depicted in Figure 2d.
Increasing the ER store loading with CDN1163, a postulated
allosteric activator of SERCA2b (sarco/endoplasmic reticu-
lum Ca2+-ATPase, isoform 2b),27 did not significantly affect
the responses to BH3I-2′ in bax−/− cells (Figure 2e). Finally,
BH3I-2′ increased apoptosis in WT cells by ~20.6± 3.8%
and necrosis by 26.1±2.7% over control levels; these effects
were completely abolished by intracellular Ca2+ chelation
with BAPTA (Po0.05; Figure 2f; bars and corresponding
images). In bax−/− cells, BH3I-2′ did not affect apoptosis and
only slightly increased necrosis (by 8.8±3.8%); the latter was
completely inhibited by BAPTA (Po0.05; Figure 2f). The
effects of BH3I-2′ on cell death were substantially less
pronounced in bax−/− cells compared to WT cells (Po0.05
for both apoptosis and necrosis; Figure 2f).
Loss of bax reduces Ca2+ release from the ER. The
effects of Bax on intracellular Ca2+ homoeostasis were
investigated in PACs that had their ER stores depleted with
the SERCA blocker thapsigargin under simultaneous inhibition
of IP3Rs (by 20mM caffeine) and RyRs (by 10 μM ruthenium
red).16,28 Average traces (Figure 3a) and average areas of
responses (Figure 3a, inset) demonstrate that [Ca2+]i elevation
caused by the ER depletion was significantly smaller in
bax−/− cells than in WT cells (Po0.001). Inhibition of Ca2+
extrusion by 1 mM La3+ preserved the difference in size of the
thapsigargin-induced Ca2+ release between WT and bax−/−
cells (Po0.01; Figure 3b) indicating that this difference
was not due to enhanced cytosolic Ca2+ extrusion in bax−/−
cells. Further, in two-photon-permeabilised PACs, thaps-
igargin also released less Ca2+ from the ER of bax−/− than
from WT cells (Po0.05; Figures 3c and d) and the app-
arent rate of release was slower in bax−/− compared to
WT cells (τ1/2=278.3±34.2 s versus 166.6±27.7 s; Po0.05;
Figure 3e). Emptying the ER store with a supramaximal dose
of acetylcholine (ACh, 10 μM) resulted in only very slightly
diminished responses in bax−/− cells in the first 100 s
(62.7±3.7 a.u.) compared to WT cells (79.2±4.4 a.u.;
Po0.01; Figures 3f and g). The second emptying of the ER
store, preceded by partial reloading in 1 mM extracellular Ca2+,
showed no statistically significant difference between WT
(45.0±2.8 a.u.) and bax−/− cells (41.9±2.0 a.u.; P=0.38;
Figures 3f and g), indicating that ER store refilling was not
substantially altered by loss of Bax. Finally, the responses to
physiological doses of ACh (100 nM) were essentially unaf-
fected as shown by sample traces (Figures 3h and i) and the
response areas (Figure 3j).
CALPs inhibit Ca2+ entry in pancreatic acinar cells.
Calcium-like peptides (CALPs) are short peptides designed
by inversion of the hydrophobic pattern of EF hand
Ca2+-binding sites,29 which generates molecules of a
complementary surface contour, capable of interacting with
the sequences of interest.30,31 Cell permeable CALP-1 and
CALP-3 can functionally mimic increased [Ca2+]i by modulat-
ing the activity of calmodulin, Ca2+ channels and pumps.32
Emptying the ER Ca2+ store with thapsigargin leads to
opening of store-operated Ca2+ entry (SOCE) channels in the
plasma membrane and influx of Ca2+ into the cytosol.33 As
seen in Figures 4a–c, thapsigargin elicits an increase in [Ca2+]i
which, in the absence of external Ca2+, is transient due to the
extrusion of Ca2+ by the plasma membrane Ca2+ pumps.
When Ca2+ is added to the external solution, [Ca2+]i increases
again, due to SOCE (Figures 4a–c). In the absence of CALPs,
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the first and second application of 10 mMCa2+ induced similar
[Ca2+]i elevations (Figure 4a). Addition of low concentrations
(10 μM) of CALP-1 (Figure 4b) or CALP-3 (Figure 4c) before
the second application of 10 mM Ca2+ substantially inhibited
Ca2+ influx, as shown by markedly reduced amplitudes
(Po0.001; Figure 4d).
CALPs reduce excessive cytosolic Ca2+ signals and
necrosis elicited by BH3I-2′. Excessive cytosolic Ca2+
signals can trigger necrosis, associated with release of
intracellular content followed by inflammation.34 Necrosis is
especially dangerous for the pancreas, where released
activated digestive enzymes cause a serious threat for the
integrity of the tissue.35,36 Therefore apoptosis, executed
by cells in a controlled manner, is a more favourable
pathway for killing cells. Here, CALPs were applied in an
attempt to reduce elevations in [Ca2+]i and necrosis caused
by BH3 mimetics. Preincubation of PACs either with 100 μM
CALP-1 or CALP-3 led to a decrease in the average
amplitude of the Ca2+ signals occurring in response to
BH3I-2′ (Po0.001 and Po0.05, respectively) compared to
the control (average traces: Figure 5a; quantitative
analysis: Figure 5b). This was due to a shift in the pattern
of cytosolic Ca2+ signals elicited by 5 μM BH3I-2′ (Figure 5c).
The consequences of the CALP-mediated reductions in the
cytosolic Ca2+ signal generation are reflected by the cell
death pattern (Figures 5d and e). In the untreated control the
majority of cells were alive (low levels of apoptosis and
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Figure 1 Loss of Bax markedly inhibits Ca2+ responses induced by BH3I-2′ and HA14-1. (a) Average Ca2+ responses (± S.E.M.) to 5 μM BH3I-2′ in PACs isolated from WT
mice (blue, n= 12), bcl-2−/− (green, n= 28), bak−/− (purple, n= 27) and bax−/− (red, n= 20). (b) Average Ca2+ responses (± S.E.M.) to 30 μM HA14-1 in PACs isolated from
WT mice (blue, n= 26), bcl-2−/− (green, n= 23), bak−/− (purple, n= 43) and bax−/− (red, n= 17). (c) The responses shown in a were quantitatively analysed by comparing the
average Ca2+ areas under traces recorded between 400 and 1000 s: WT (blue, n= 12, 304.6±39.7 a.u.), bcl-2−/− (green, n= 28, 256.4± 25.5 a.u.), bak−/− (purple, n= 27,
312.0± 50.9 a.u.) and bax−/− (red, n= 20, 46.5± 11.7 a.u.). (d) The responses shown in b were quantitatively analysed by comparing the average areas under traces recorded
between 400 and 1000 s: WT (blue, n= 26, 216.5± 35.1 a.u.), bcl-2−/− (green, n= 23, 266.6± 36.1 a.u.), bak−/− (purple, n= 43, 155.4± 22.1 a.u.) and bax−/− (red, n= 17,
47.0± 13.6 a.u.). (e) Patterns of Ca2+ responses to BH3I-2′ averaged in a. Four types were identified: (1) Ca2+-induced Ca2+ release (CICR) type followed by a sustained
elevation (plateau), (2) Ca2+ plateau with no CICR, (3) Ca2+ transients (CICR) with no plateau formation, (4) no response. Insets show sample traces of each identified type of
response (scale: x axis: 200 s; y axis: 1.0 F/F0, Fluo-4). (f) Patterns of Ca
2+ responses to HA14-1 averaged in b. The responses were classified as in e. Insets show sample traces
of each identified type of response (scale: x axis: 200 s; y axis: 1.0 F/F0, Fluo-4)
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Figure 2 Loss of Bax reduces BH3I-2′-induced Ca2+ leak from the ER and cell death in PACs. (a) Average traces (± S.E.M.) showing Ca2+ release from the ER of
permeabilised WT (blue, n= 10) and bax−/− (red, n= 14) PACs induced by 5 μM BH3I-2′. Inset shows individual traces. (b) Dot chart shows individual and average (± S.E.M.)
response areas below the baseline calculated between 100 and 600 s for the traces from a: WT (123,6±19.7 a.u.) and bax−/− (53.3± 6.3 a.u.). (c) Dot chart shows the half-
times (τ1/2) of the reduction in fluorescence of the Ca
2+ indicator in the ER (and thus [Ca2+]ER) towards the final levels calculated for the traces depicted in a. (d) Images of a PAC
doublet before and after two-photon permeabilisation. Black arrow shows the site of permeabilisation. (e) Bar chart shows average areas under traces (± S.E.M.) calculated bet-
ween 200 and 1000 s for bax−/− cells pre-incubated for 2 h with 10 μMCDN1163 (grey, n= 61, 88.3±9.0 a.u.) or with 0.05% DMSO (vehicle control, red, n= 89, 73.3± 7.1 a.u.)
and then treated with 5 μM BH3I-2′. Inset shows averaged traces (± S.E.M.). (f) Apoptosis and necrosis induced by 30 min incubation with 5 μM BH3I-2′ in WTand bax−/− PACs
with or without 15 min pretreatment with 25 μM BAPTA. Blue bars represent apoptotic cells, and red – necrotic. N= 3 for all the groups; individual values are indicated with grey
dots. Below each pair of bars, sample images show morphology (transmitted light images) and typical annexin V (green), and propidium iodide (red) staining of PACs in the
experiment
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necrosis are due to enzymatic digestion of the tissue).
Incubation with 5 μM BH3I-2′ resulted in a 19.1± 4.9%
increase in apoptosis and a 31.7± 8.1% increase in necrosis
over the control levels (similar as in Figure 2f). In the
presence of CALP-1, necrosis was significantly decreased
(Po0.05), whereas apoptosis markedly increased (Po0.05)
compared to BH3I-2′ alone. In contrast, CALP-3 did not
affect apoptosis, but caused a reduction in necrotic cells
(Po0.05) accompanied by an increase in the proportion of
live cells (Po0.05).
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Figure 3 Loss of Bax reduces Ca2+ release from the ER. (a) Average Ca2+ responses (± S.E.M.) induced by 10 μM thapsigargin (Tg) in WT (blue, n= 9) and bax−/− (red,
n= 12) PACs. IP3Rs and RyRs were inhibited by 20 mM caffeine (Caff) and 10 μM ruthenium red (RR), respectively. Inset: average areas under traces calculated between 400
and 1400 s for the individual recordings in WT (305.4±15.5 a.u.) and bax−/− (168.7± 8.9 a.u) cells. (b) Average Ca2+ responses (± S.E.M.) induced by 10 μM Tg in WT (blue,
n= 24) and bax−/− (red, n= 21) PACs in the presence of 20 mM Caff and 10 μM RR under inhibition of Ca2+ extrusion by 1 mM La3+. Inset: average areas under traces
(± S.E.M.) calculated between 400 and 1400 s for the individual recordings in WT (616.3±26.5 a.u.) and bax−/− (469.4± 35.9 a.u) cells. (c) Average traces (± S.E.M.) showing
Ca2+ release from the ER of permeabilised WT (blue, n= 7) and bax−/− (red, n= 7) PACs induced by 2 μM Tg. Inset shows individual traces. (d) Dot chart shows individual and
average (± S.E.M.) areas calculated between 100 and 600 s for the traces from c: WT (151.7±25.1 a.u.) and bax−/− (83.1± 9.1 a.u.). (e) Dot chart shows the half-times (τ1/2) of
the reduction in fluorescence of the Ca2+ indicator in the ER (and thus [Ca2+]ER) towards the final levels calculated for the traces depicted in c. (f) Average Ca
2+ responses
(± S.E.M.) to two applications of supramaximal doses of ACh (10 μM) in the absence of extracellular Ca2+, separated by partial reloading in 1 mM extracellular Ca2+ for 15 min.
(g) Average areas under traces (± S.E.M.) calculated in the first 100 s after application of ACh for the individual recordings averaged in f. (h) 100 nM ACh induces Ca2+
oscillations in WT PACs (representative trace, n= 12). (i) 100 nM ACh induces Ca2+ oscillations in bax−/− PACs (representative trace, n= 25). (j) Dot chart shows individual and
average (± S.E.M.) response areas calculated between 100 and 600 s of each recording from WT and bax−/− cells
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CALPs reduce excessive cytosolic Ca2+ responses and
necrosis elicited by gossypol. It has been reported that
gossypol is also capable of mobilising intracellular Ca2+.37,38
Similarly to BH3I-2′ and HA14-1, in the absence of
extracellular Ca2+, bax−/− cells did not respond to gossypol
(Figure 6a, black trace). In WT cells in the presence of
external Ca2+, 20 μM gossypol alone caused an increase in
[Ca2+]i reaching a sustained elevated plateau (Figure 6a).
Preincubation either with 100 μM CALP-1 or with CALP-3 led
to a decrease in the magnitude of the Ca2+ responses to
gossypol (Figures 6a and b; Po0.001); CALP-1 markedly
decreased the proportion of cells that responded at all
(Figure 6c). The effects of CALP-1 and CALP-3 on gossypol-
induced cell death (Figures 6d and e) were very similar to
those for BH3I-2′ (Figure 5d). In the presence of CALP-1,
necrosis was markedly decreased (Po0.05) and the propor-
tion of apoptotic cells was increased (Po0.05). CALP-3
reduced gossypol-induced necrosis (Po0.05) and increased
the fraction of live cells (Po0.05).
CALPs do not markedly affect physiological Ca2+ signals
in acinar cells. The ability of CALPs to reduce excessive
pathological Ca2+ signal generation is potentially very useful
but given the crucial role of Ca2+ in the regulation of a wide
variety of intracellular processes, it was important to test
whether CALPs also affect physiological Ca2+ signalling.
Nanomolar doses of ACh trigger enzyme secretion in PACs,
an event controlled by Ca2+ signals.24 Here, 50 nM ACh
induced repetitive [Ca2+]i oscillations (Figure 7a). Preincuba-
tion with either 100 μM CALP-1 (Figure 7b) or CALP-3
(Figure 7c) did not affect the ACh-elicited signals. The
average areas of the responses to ACh in the presence
and absence of CALPs were not found significantly different
(Figure 7c, inset). Another secretagogue of the exocrine
pancreas,39 CCK (5 pM), induced oscillatory Ca2+ responses
in acinar cells (Figure 7d). The presence of either CALP-1
(Figure 7e) or CALP-3 (Figure 7f) did not block the CCK-
elicited responses, but the overall pattern was slightly
changed (Figure 7g).
The effects of CALPs on cell death are not limited to BH3-
mediated necrosis. As the primary mechanism by which
CALPs exert their effects is the pre-activation of EF hand
Ca2+-binding sites on a wide variety of intracellular targets29
and inhibition of Ca2+ entry (Figures 4a–d), it is unlikely that
CALP-mediated reduction in excessive Ca2+ signals and
necrosis is limited only to the effects induced by BH3
mimetics. Menadione was previously shown to induce
Ca2+-dependent cell death in PACs.40 Here, 5 μM menadione
was combined with a high physiological concentration of ACh
(100 nM) in order to induce Ca2+-dependent cell death of
similar proportions of apoptosis and necrosis (25.1± 5.0%
and 20.7±1.7%, respectively; Figure 7h; sample images in
Figure 7i) to those caused by BH3I-2′ (Figure 5d) or gossypol
(Figure 6d). In this protocol 100 μM CALP-1 decreased cell
necrosis to control levels (Po0.05) while increasing slightly
the proportions of both live and apoptotic cells; whereas
100 μM CALP-3 substantially reduced necrosis (Po0.05),
leading to an increase in the number of live cells (Po0.05).
The apoptotic fraction was essentially unaffected by CALP-3.
Discussion
It is now commonly accepted that Bcl-2 proteins are distributed
in different cell compartments, not only at the outer mitochon-
drial membrane, but also in the cytosol, at the nuclear
envelope and the ER.41–43 An increasing number of reports
indicates that Bcl-2 itself may either directly or indirectly
modulate intracellular Ca2+ fluxes such as: (1) Ca2+ release
from the ER by binding to IP3Rs or RyRs;
44–46 (2) Ca2+
reuptake into the ER by SERCA;47 (3) cellular Ca2+ extrusion
by PMCA (plasma membrane Ca2+ ATPase);48 (4) and
mitochondrial Ca2+ load.49
We have previously demonstrated that the BH3 mimetics
BH3I-2′ and HA14-1 induce Ca2+ release from the intracellular
stores in mouse PACs and in the rat pancreatic cancer cell line
AR42J.16 This Ca2+ release was not completely blocked by
inhibition of IP3Rs and RyRs indicating involvement of other
Ca2+ channels. We have also shown that BH3I-2′ and HA14-1
displace Bax from Bcl-2 and Bcl-xL.16 Here we provide new
insights into the mechanism of this phenomenon by demon-
strating that loss of Bax, but not Bak or Bcl-2, substantially
inhibited Ca2+ responses to BH3I-2′ (Figure 1a), HA14-1
(Figure 1b) and gossypol (Figure 6a) in the absence of
extracellular Ca2+. HA14-1 and gossypol were suggested to
have off-target effects,50,51 and recently a novel Bcl-2 inhibitor,
ABT-199, was found not to affect intracellular Ca2+
signalling.52 In our experiments not only the responses to
HA14-1 and BH3I-2′ were markedly inhibited in bax−/− PACs
(Figures 1a and b) but also BH3I-2′-elicited apoptosis was
completely abolished (Figure 2f), indicating that these effects
were dependent on Bax. Low levels of necrosis in bax−/− cells
may indeed suggest a Bax-independent killing component
in the mechanism of BH3I-2′ action. Importantly, BH3I-2′-
induced cell death in PACs appears to be mediated by Ca2+ as
it was blocked by chelation of intracellular Ca2+ with BAPTA
(Figure 2f).
Our results appear to link Bax with the process of passive
Ca2+ leak from the ER. The leak, unmasked by thapsigargin,
developed more slowly in bax−/− cells compared to WT cells
(Figures 3c and e). Currently there is an on-going dispute
about the nature of the channels mediating this process. As
Bax can localise to the ER membranes53 and given that its
structure resembles that of pore-forming bacterial toxins,54,55
Bax itself might be able to form a channel permeable to ions
and thus contribute to the passive Ca2+ leak. Two out of seven
α-helices of Bax were suggested to function as pore-forming
domains, but possibly more than one monomer of Bax would
need to form a functional ion-permeable pore.56,57 Alterna-
tively, as opposed to acting as a channel itself, Bax could
directly or indirectly regulate the ER Ca2+ leak mediated by
other channels. Consequently, it could be speculated that
application of a BH3mimetic increases the unbound fraction of
Bax, which activates Ca2+ channels in the ER, thus potentiat-
ing the leak (Figure 8). The leak may be further amplified by
IP3Rs and RyRs.
The reduced cytosolic Ca2+ release in response to
thapsigargin treatment in bax−/− cells could, in principle, be
explained by a diminished resting ER Ca2+ content. However,
as ACh-induced oscillations were essentially unaffected in
bax−/− cells (Figures 3h–j), this may indicate that the [Ca2+]ER
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has not been substantially affected by loss of Bax. Previous
experiments demonstrated that ACh-evoked short-lasting
Ca2+ spikes in PACs are very sensitive to even minor
reductions in [Ca2+]ER and cease after a relatively modest
decrease in [Ca2+]ER.
58 This could shed new light on a
seeming discrepancy found in the previous studies, whereby
both knockdown59,60 and overexpression61,62 of Bax led to a
reduction in Ca2+ responses induced by various agonists or
inhibition of SERCA. It is likely that upon loss of Bax, some of
the leak channels are inactive, and those that remain active
may be sensitive to changes in [Ca2+]ER and, for example,
close early in the release period thereby limiting Ca2+ release
from the ER. In contrast, overexpression of Bax may lead to an
increased basal leak, which results in a decrease in resting
[Ca2+]ER and thus dampens Ca
2+ responses. Finally, under
normal conditions, Bax is sequestrated by anti-apoptotic Bcl-2
family proteins. But any shifts in the balance between anti- and
pro-apoptotic Bcl-2 members may promote mechanisms that
either favour pro-survival Ca2+ transients or larger pro-
apoptotic Ca2+ signals.63
Further, our results show that the BH3 mimetics, BH3I-2′
and gossypol not only induce apoptosis in PACs but also
cause substantial levels of necrosis (Figures 5d and 6d). Cell
death in PACswas a downstream effect of large cytosolic Ca2+
signals triggered by application of BH3 mimetics, as (1) Ca2+
chelation by BAPTA completely abolished both apoptosis and
necrosis induced by BH3I-2′ and (2) reduction of Ca2+ signals
elicited by CALP-1 or CALP-3 (Figures 5a and 6a) led to a
significant decrease in BH3I-2′- as well as gossypol-induced
necrosis (Figures 5d and 6d). CALP-1 was shown to be
particularly promising, as it effectively shifted the cell death
mode from necrosis to apoptosis. In contrast, CALP-3
substantially reduced BH3 mimetic-induced necrosis while
increasing the fraction of live cells. Both CALPs were capable
of inhibiting Ca2+ entry (Figures 4a–d), even though they differ
in structure. CALP-1 has been designed to interact with EF
hand Ca2+-binding sites of troponin C, whereas CALP-3 is
complementary to the EF hand motif of calmodulin.32 It is
therefore likely that the two CALPsmight preferentially interact
with different intracellular targets, for example, Ca2+ channels
regulated by Ca2+ versus calmodulin, abundant in PACs.64
This could explain different effects on BH3 mimetic-induced
cell death. Previously we demonstrated that CALP-3 efficiently
inhibited Ca2+ responses induced by ethanol in PACs and we
attributed this effect to activation of calmodulin.65 The exact
assessment of binding affinities of CALPs to intracellular
targets exceeds the scope of thiswork. It is clear, however, that
the effects of CALPs on cell death are not limited to BH3
mimetics, as necrosis triggered by ACh and menadione was
also inhibited in the presence of CALPs (Figure 7h).
Considering the vast spectrum of targets affected by
CALPs, it was important to test whether application of
these compounds would affect not only pathological Ca2+
elevations but also physiological Ca2+ signals. In PACs,
nanomolar doses of ACh and picomolar concentrations of
CCK are known to trigger Ca2+ oscillations, which regulate
pancreatic enzyme secretion.24 In our experiments neither
CALP-1 nor CALP-3 markedly affected responses to ACh
(Figures 7a–c), whereas in the presence of CALP-3,
CCK-elicited Ca2+ oscillations were slightly reduced but not
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Figure 4 CALPs inhibit Ca2+ entry in PACs. (a) The ER store was emptied with thapsigargin (Tg) in the absence of extracellular Ca2+. Two consecutive applications of
10 mM extracellular Ca2+ triggered Ca2+ entry into the cytosol (sample trace, n= 19); control experiment for b and c. (b) The ER store was emptied with Tg in the absence of
extracellular Ca2+. Application of 10 mM extracellular Ca2+ triggered Ca2+ entry into the cytosol. The first response to 10 mM Ca2+ was an internal control; the second response
was inhibited in the presence of 10 μM CALP-1 (sample trace, n= 19). (c) The ER store was emptied with Tg in the absence of extracellular Ca2+. Application of 10 mM
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completely inhibited (Figures 7d–g). The previously
demonstrated inhibition of Ca2+ influx into PACs by the CRAC
channel inhibitor GSK-7975A also affected only pathological
Ca2+ elevations but not the oscillations induced by physiolo-
gical concentrations of ACh or CCK.66
Although it can be triggered by sustained elevations of
[Ca2+]i, necrosis generally lacks intracellular regulatory
mechanisms. This severely limits possible therapeutic
approaches in diseases where necrosis plays a major role,
such as acute pancreatitis. Inhibition of SOCE has already
been demonstrated to decrease cell death in vitro66 and
in vivo.67 This study provides another proof-of-principle
demonstration that even non-specific attenuation of intracel-
lular Ca2+ fluxes can dampen pathophysiological Ca2+
responses and thus result in necrosis inhibition (CALP-3) or
a significant shift in cell death towards apoptosis (CALP-1).
Our results indicate that application of CALPs, especially
CALP-1, could improve the outcome of BH3 mimetic-based
therapies. Although the pharmacokinetic properties of
CALPs have not yet been studied in detail, it is likely that
CALPs share characteristics of other short peptides, such as
limited cell permeability and metabolic instability.68 However,
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Figure 5 CALPs reduce Ca2+ responses and cell death induced by BH3I-2′. (a) Average Ca2+ responses (±S.E.M.) in PACs to 5 μM BH3I-2′ (blue, n= 22) and to BH3I-2′ in
the presence of 100 μM CALP-1 (red, n= 25) or 100 μM CALP-3 (green, n= 28). (b) The responses shown in a were quantitatively analysed by comparing the average areas
under traces recorded between 200 and 1000 s: control (blue, n= 22, 434.1±57.6 a.u.), CALP-1 (red, n= 25, 85.9± 22.3 a.u.) and CALP-3 (green, n= 28, 252.3± 39.2 a.u.).
(c) Distribution of different types of Ca2+ responses (averaged in a) induced by 5 μM BH3I-2′ in the presence/absence of 100 μM CALP-1 or CALP-3. Insets show sample traces
of different response patterns; colours and scale values (x axis: 200 s; y axis: 0.5 R/R0, Fura-2) correspond with those shown in a. The mimetic alone predominantly induced a
slow rise in [Ca2+]i, which started soon after the application. Eventually a steady elevated plateau was attained in the vast majority of cases (82%). In a small proportion of cells, the
initial [Ca2+]i rise was delayed (18%). In the presence of CALP-1, similar large responses reaching an elevated [Ca
2+]i plateau were recorded in only 32% of cells and 28% of the
responses were delayed. Importantly, 20% of the cells responded only with a single cytosolic Ca2+ transient with no plateau formation, and the remaining 20% of the cells did not
respond within the time course of the experiment. In the presence of CALP-3, 64% of the cells showed a typical [Ca2+]i elevation in response to BH3I-2′, in 11% of cells the
responses were delayed, and the remaining 25% did not respond at all. (d) Cell death induced by 30 min incubation with 5 μM BH3I-2′ in PACs after 15 min pretreatment with
100 μM CALP-1 or CALP-3. Grey bars represent live cells, blue – apoptotic cells and red – necrotic. N= 3 for all the groups; individual values are shown with different markers
(O,▲,▬). (e) Sample images show typical annexin V (green) and propidium iodide (red) staining of PACs used in the experiment shown in d
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development of synthetic non-peptide compounds activating
EF handCa2+-bindingmotifs could potentially overcome these
limitations, providing a useful pharmacological switch of cell
death mode, particularly in cancer therapies.
Materials and Methods
Reagents. The main reagents for cell isolation and imaging include: Fluo-4 AM,
Fura-2 AM, Fluo-5N AM and BAPTA AM (ThermoFisher Scientific, Paisley, UK);
collagenase (Worthington Biochemical Corporation, Lakewood, NJ, USA); inorganic
salts (Sigma-Aldrich, Gillingham, UK). Other reagents: HA14-1 (Alexis Biochem-
icals, San Diego, CA, USA); BH3I-2′, gossypol (Santa Cruz Biotechnology, Dallas,
TX, USA); caffeine and thapsigargin (Calbiochem, Nottingham, UK); CALP-1,
CALP-3, ruthenium red and CDN1163 (Tocris Bioscience, Bristol, UK). NaHEPES
buffer was prepared as follows (mM): NaCl 140, KCl 4.7, HEPES 10, MgCl2 1,
glucose 10; pH 7.2. KHEPES (intracellular solution) consisted of (mM): KCl 130,
NaCl 18, MgCl2 1, HEPES 10, ATP 3, EGTA 0.1, CaCl2 0.05; pH 7.2.
Animals. All procedures involving animals were performed in accordance with
the UK Home Office regulations. C57BL/6J mice (male, 6–8 weeks old, 23± 3 g
weight) were supplied by Charles River Laboratories (Margate, UK); transgenic
mice bcl-2−/− (B6;129S2-BCL-2tm1Sjk/J), bax−/− (B6.129X1-Baxtm1Sjk/J) were
obtained from The Jackson Laboratories (Bar Harbor, ME, USA); bak−/−
(B6.129-Bak1tm1Thsn/J) colony was a gift of Professor David Mark Pritchard
(University of Liverpool); bax−/− strain extensively crossed into the CD1 background
was also obtained from Professor Alun Davies (Cardiff University).69 Transgenic
mice were bred in house either from null (bak−/−) or heterozygous (bcl-2−/−,
bax−/−) parents; the genotype of each mouse was confirmed by PCR reaction with
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Figure 6 CALPs reduce Ca2+ responses and cell death induced by gossypol. (a) Average Ca2+ responses (± S.E.M.) in PACs to 20 μM gossypol (blue, n= 20) and to
gossypol in the presence of 100 μM CALP-1 (red, n= 15) or CALP-3 (green, n= 14); black trace shows lack of responses to 20 μM gossypol in bax−/− PACs in the absence of
extracellular Ca2+ (n= 3). (b) The responses shown in (a) were quantitatively analysed by comparing the average areas under traces recorded between 200 and 1000 s: control
(blue, n= 20, 721.1±79.4 a.u.), CALP-1 (red, n= 15, 213.4± 55.1 a.u.) and CALP-3 (green, n= 14, 320.6± 29.6 a.u.). (c) Distribution of different types of Ca2+ responses
(averaged in a) induced in PSCs by 20 μM gossypol in the presence/absence of 100 μM CALP-1 or CALP-3. Insets show sample traces of different response patterns; colours
and scale values (x axis: 200 s; y axis: 0.5 R/R0, Fura-2) correspond with those shown in a. 65% of the cells responded immediately, whereas responses in 35% of cells were
delayed. CALP-1 decreased the proportion of cells that responded to gossypol either immediately (33%) or with a delay (27%) and as many as 40% of cells did not show any [Ca2
+]i elevation. In contrast, CALP-3 did not affect the pattern of the responses to gossypol – all cells developed either immediate (64%) or delayed (36%) elevations in [Ca
2+]i, but of a
lower amplitude than in cells treated with gossypol alone (shown in a). (d) Apoptosis and necrosis induced by 30 min incubation with 5 μM gossypol in PACs after 15 min
pretreatment with 100 μM CALP-1 or CALP-3. Grey bars represent live cells, blue – apoptotic cells and red – necrotic. N= 3 for all the groups; individual values are shown with
different markers (O,▲,▬). (e) Sample images show typical annexin V (green) and propidium iodide (red) staining of PACs used in the experiment shown in d
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Figure 7 CALPs do not inhibit physiological Ca2+ responses in PACs. (a) 50 nM ACh induces Ca2+ oscillations in PACs (representative trace, n= 15). (b) 50 nM ACh induces
Ca2+ oscillations in PACs in the presence of 100 μM CALP-1 (representative trace, n= 12). CALP-1 was present 200 s before the addition of ACh. (c) 50 nM ACh induces Ca2+
oscillations in PACs in the presence of 100 μM CALP-3 (representative trace, n= 10). CALP-3 was present 200 s before the addition of ACh. Inset shows average areas under
traces (± S.E.M.) calculated for 600 s after response induction by ACh (blue, 25.8±4.0 a.u.), ACh in the presence of CALP-1 (red, 20.2± 3.3 a.u.) and ACh in the presence of
CALP-3 (green, 21.6± 4.5 a.u.). (d) Typical large Ca2+ transients (upper trace), mixed responses (middle trace) and small oscillations (lower trace) induced by 5 pM CCK in PACs
(representative traces, n= 9). Black arrow indicates addition of CCK. (e) Typical large Ca2+ transients (upper trace), mixed responses (middle trace) and small oscillations (lower
trace) induced by 5 pM CCK in PACs in the presence of 100 μM CALP-1 (representative traces, n= 15). CALP-1 was present 200 s before the addition of CCK. (f) Typical large
Ca2+ transients (upper trace), mixed responses (middle trace) and small oscillations (lower trace) induced by 5 pM CCK in PACs in the presence of 100 μM CALP-3
(representative traces, n= 11). CALP-3 was present 200 s before the the addition of CCK. (g) Distribution of different types of Ca2+ responses (representative traces shown in
d–f) induced by 5 pM CCK in the presence/absence of 100 μM CALP-1 or 100 μM CALP-3. The majority of the control responses (56%) were large transients, 22% were small
oscillations and the remaining 22% consisted of both large and small Ca2+ spikes. Preincubation with 100 μM CALP-1 led to a slight decrease in the proportion of cells that
responded with large Ca2+ oscillations (47%) accompanied by an increase in small responses (33%). CALP-3 reduced large transients even further (18%) resulting in higher
proportions of cells responding with both large and small (45%), or small oscillations only (36%). (h) Apoptosis and necrosis induced by 30 min incubation with 5 μM menadione
(Men) and 100 nM ACh in PACs after 15 min pretreatment with 100 μM CALP-1 or CALP-3. Grey bars represent live cells, blue – apoptotic cells and red – necrotic. N= 3 for all
the groups; individual values are shown with different markers (O,▲,▬). (i) Sample images show typical annexin V (green) and propidium iodide (red) staining of PACs used in
the experiment shown in h
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primers suggested by the supplier. All animals were housed in the institutional
animal unit, maintained on a 12 h light cycle on a standard rodent chow diet with
free access to water. The mice were killed according to Schedule 1 of Animals
(Scientific Procedures) Act 1986, dissected and the pancreatic tissue was removed
for further experimental procedures.
Isolation of pancreatic acinar cells. PAC isolation and most of the
experimental work was carried out in NaHEPES buffer. Unless otherwise stated,
NaHEPES was supplemented with 1 mM Ca2+. Freshly isolated pancreas was
washed twice in NaHEPES, injected with collagenase (200 µ/ml, in NaHEPES) and
subsequently incubated at 37 °C for 15 min in the collagenase solution to allow
digestion of the tissue. After incubation, the pancreas was broken down by pipetting,
suspended in NaHEPES, spun (1 min, 0.2 × g), resuspended in NaHEPES and
spun again. Finally, isolated PACs were suspended in NaHEPES and loaded with a
Ca2+ sensitive dye as described below.
Cytosolic Ca2+ measurements. Isolated PACs were loaded at room
temperature with one of the Ca2+ indicators: 5 μM Fluo-4 AM for 30 min or 10 μM
Fura-2 AM for 1 h. After the incubation the cells were resuspended in fresh
NaHEPES and used for experiments at room temperature in a flow chamber
perfused with NaHEPES-based extracellular solution. Experiments with Fluo-4 AM
were performed using the Leica confocal microscope TCS SPE (Leica
Microsystems, Milton Keynes, UK): × 63 oil objective, excitation 488 nm, emission
500–600 nm. Static images were taken at 512 × 512 pixel resolution and series of
images were recorded at 256 × 256 pixel resolution, two consecutive frames were
averaged. Fluorescence signals were plotted as F/F0, where F0 was an averaged
signal from the first ten baseline images. Experiments with Fura-2 AM were
performed using the Nikon Diaphot 200 imaging system (Nikon, Kingston, UK):
excitation at 365 and 385 nm, emission at 510 nm. The signals were plotted as
365/385 nm ratio or the ratio normalized to baseline values (R/R0).
ER Ca2+ measurements. PACs were loaded with 5 μM Fluo-5N AM in
NaHEPES for 45 min at 37 °C. After the incubation, the cells were resuspended in
fresh NaHEPES and used for experiments at room temperature in a flow chamber
perfused with KHEPES-based intracellular solution. The cells were permeabilised
with two-photon laser beam (720–750 nm),70 which was applied at a small area of
the plasma membrane of a PAC. The experiments were performed using the Leica
two-photon confocal microscope TCS SP5 with the same settings as for Fluo-4 AM
(see above).
Cell death assay. Cell death assay was performed using Annexin V-FITC
Apoptosis Detection Kit (Sigma-Aldrich) according to a modified manufacturer′s
protocol. PACs were isolated as described above and divided equally into four
experimental groups. Two samples were pretreated with 100 μM CALP-1 or 100 μM
CALP-3 for 15 min at room temperature; the remaining two were incubated without
pretreatment. Then cell death was induced for 30 min in both samples containing
CALPs and in one untreated sample. Depending on the experiment, either one of
BH3 mimetics was used (5 μM BH3I-2′ or 5 μM gossypol) or 5 μM menadione
together with 100 nM ACh. Analogical experiments were performed with 15 min
pretreatment with BAPTA instead of CALPs. The control samples were left
untreated. Fifteen minutes before the end of the incubation, annexin V-FITC and
propidium iodide were added to all samples. The cells were visualised with the Leica
confocal microscope TCS SPE. Annexin V-FITC specifically stained apoptotic cells
(excitation: 488 nm, emission: 510–570 nm), whereas propidium iodide was used
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Figure 8 Schematic illustration of proposed effects of BH3 mimetics and CALPs on intracellular Ca2+ homoeostasis. BH3 mimetics (such as BH3I-2′ or gossypol) disrupt the
interaction between anti-apoptotic Bcl-2 and pro-apoptotic Bax. Unbound Bax may either form channels in the ER membranes or interact with the ER leak channel triggering Ca2+
release from the ER stores. Ca2+ release is amplified by IP3Rs and RyRs. These receptors can be inhibited by caffeine and ruthenium red (RR), respectively. CALPs affect
multiple targets via interaction with their EF hand motifs, for example, inhibit SOCE and activate calmodulin (CaM)
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for detection of necrotic cells (excitation: 535 nm, emission: 585–705 nm). Multiple
pictures (20–35) per treatment group were taken; live, apoptotic and necrotic cells
were counted in each treatment group.
Statistical analysis. For quantitative analysis of Ca2+ responses, areas under
individual traces were calculated according to the formula:
P
F=F0  F0ð Þ ´Dt ,
where F is the recorded fluorescence (or ratio for Fura-2), F0 is the baseline
fluorescence (or ratio) and Δt – time interval. Obtained values were then averaged
and presented as bar charts with S.E.M. The Student′s t-test was applied for
statistical comparison. The significance threshold was set at 0.05 and the range was
indicated by asterisks (*Po0.05, **Po0.01, ***Po0.001). Where applicable,
N indicates the number of individual experiments, whereas n – individual cells.
For cell death assays, three independent experiments were performed for each
treatment group; average values and S.E.M. were calculated and the results
presented as bar charts. Statistical analysis was performed using the non-parametric
Mann–Whitney U-test with the significance threshold set at 0.05.
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